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HDAC inhibitors have been proposed as anticancer agents. However, their roles in innate genes expression remain
not well known. Cathelicidin LL-37 is one of the few human bactericidal peptides, but the regulation of histone
acetylation on LL-37 expression in airway epithelium remains largely unknown. Therefore, we investigated the
effects of two non-selective HDACi, trichostatin A (TSA) and sodium butyrate (SB), on the expression of the
cathelicidin LL-37 in human airway epithelial cells. LL37 in human NCI-H292 airway epithelial cells and the primary
cultures of normal nasal epithelial cells(PNEC) in response to HDAC inhibitors with or without poly (I:C) stimulation
was assessed using real-time PCR and western blot. In parallel, IL-6 expression was evaluated by ELISA. Our results
showed that HDAC inhibitors up-regulated LL-37 gene expression independent of poly (I:C) stimulation in PNEC as
well as in NCI-H292 cells. HDAC inhibitors increased LL37 protein expression in NCI-H292 cells but not in PNEC. In
addition, HDAC inhibitors significantly inhibited poly (I:C)-induced IL-6 production in both of the epithelial cells. In
conclusion, HDAC inhibitors directly up-regulated LL-37 gene expression in human airway epithelial cells.
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Recent studies suggest that epigenetics have an important
role in regulating innate immunity and that the manifest-
ation and severity of diseases may be influenced by epigen-
etic factors. Epigenetic modifications play an important
role in the regulation of gene expression and a common
mechanism in epigenetics is the control of the accessibility
of the transcriptional machinery to promoter and enhancer
elements in the genome. Histone modification through re-
versible acetylation is a crucial event in gene transcription
regulation [1-3]. The net state of histone acetylation is reg-
ulated by the opposing actions of histone acetyltransferases
(HATs) and histone deacetylases (HDACs). Small changes
in the HAT/HDAC balance could affect transcription of
many inflammatory genes, potentially having a profound
effect on the initiation and duration of inflammatory* Correspondence: wangdehuient@sina.com
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reproduction in any medium, provided the orresponses [4,5]. Yin et al [6] reported on bacteria-specific
innate immune responses via epigenetic regulation in gin-
gival epithelial cells.
The respiratory epithelium is an important interface
with the environment and it is now well accepted that the
epithelium is not only just a physical barrier, but plays an
active role in innate and adaptive immunity [7]. Antibac-
terial peptides are an integral part of the epithelial defence
barrier that provides immediate protection against infec-
tion. Cathelicidins are a family of antimicrobial peptides
and LL-37, the only cathelicidin in humans, plays a critical
role in the defension of epithelium against the micro-
organism and is produced by neutrophils, macrophages,
and various epithelial cells as well [8].
Increasing evidence suggests that HDAC inhibitors
down-regulated the expression of numerous host defense
genes including pattern recognition receptors and cyto-
kines. In this study, we wanted to explore the effect of
HDAC inhibitors on the expression of LL-37 in airway epi-
thelium in the context of the viral double-stranded RNA-
mimic poly(I:C).This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Materials
Bronchial Epithelial Basal Medium (BEBM) with Bron-
chial Epithelial Growth Media(BEGM) SingleQuots were
purchased from Lonza Walkersville, Inc. Poly(I:C), TSA,
sodium butyrate, L-glutamine, pronase (type XIV prote-
ase) and 0.25% trypsin-0.02% EDTA were purchased
from Sigma Chemical Co (St Louis, MO, USA).
NCI-H292 human airway epithelial cells were purchased
from American Type Culture Collection, Manassas, VA,
USA and Shanghai Institutes for Biological Sciences
(SIBS). Anti-Cathelicidin antibody was purchased from
Abcam. Beta-actin antibody and HRP-linked antibody
were purchased from Cell Signaling Technology. Fetal
bovine serum, penicillin and streptomycin were pur-
chased from HyClone (Logan, UT, USA). RPMI 1640
and trizol medium were purchased from Life Technolo-
gies, Inc., Gaitersburg, MD, USA. Cell Counting Kit 8
was purchased from Dojindo (Kumamoto, Japan). First
strand cDNA synthesis kit was purchased from
Fermentas GmbH(St Leon-Rot, Germany).NCI-H292 human airway epithelial cell culture
NCI-H292 human airway epithelial cells were cultured as
reported before [7]. Briefly, NCI-H292 cells were cultured
in RPMI 1640 medium supplemented with 1.25 mM of L-
glutamine, 100 U/mL of penicillin, 100 μg/mL of strepto-
mycin and 10% (v/v) of fetal bovine serum in six-well
plates. Cells were grown in fully humidified air containing
5% of CO2 at 37°C and were sub-cultured weekly.Isolation and culture of human nasal epithelial cells
Primary nasal epithelial cells (PNEC) were isolated from
normal middle turbinate that was obtained from patients
who underwent endoscopic endonasal surgery in pituitary
adenoma patients who had given their written informed
consent in accordance with a study protocol approved by
the Ethics Committee of Eye and ENT Hospital of Fudan
University. Briefly, the normal middle turbinate was
digested using 0.2% pronase in culture medium at 37°C
for one hour for dissociation of the mucosal epithelial
cells. After digestion, the dissociated cells were washed
with PBS, followed by the centrifuge(400 g×5 min). The
cell pallet was resuspended with culture medium (BEBM
supplemented with BEGM SingleQuots) and plated on a
100 mm culture dish at 37°C for 2 hours to remove fibro-
blasts, myocytes, and endothelial cells. Then the harvested
epithelial cells in the supernatant were grown with culture
medium in a 5% CO2 incubator at 37°C. After confluence,
the cells were detachment with 0.25% trypsin-0.02% EDTA
and then the cells were sub-cultured in 6-well tissue cul-
ture plates.Preparation for stimulation experiment
After reaching 80% confluence, the NCI-H292 cells were
starved overnight in serum-free RPMI 1640 medium,
followed by the stimulation in serum-free medium; PNEC
cultured in tissue culture plates were starved overnight in
BEBM medium (without BEGM SingleQuots), and subse-
quently stimulated in BEBM medium.Measurement of cell viability
NCI-H292 and primary nasal epithelial cells viability
were assessed 24 h after stimulation by incubating cells
with Cell Counting Kit 8 according to the manufac-
turer’s instructions.Enzyme-linked immunosorbent (ELISA) assay
After stimulation, 1 ml of the supernatant in each well
was collected; centrifuge (5000 rpm for 5 min) and the
cell-free supernatants were stored at −20°C until ana-
lysis. The level of IL-6 in supernatant was analyzed using
ELISA. A Standard curve was made in each plate with
the highest concentration of 20000 pg/ml followed by
2-fold dilution. Each sample was measured at 1, 10,
or 100 times dilution.
RNA isolation and Real-time PCR
Total RNA for each sample was isolated using trizol
according to manufacturer’s protocol. RNA purification
was performed using nucleospin RNA II (Machery-Nagel,
Germany). RNA concentration was measured using
the nanodrop ND-1000 (NanoDrop Technologies Inc.,
Wilmington, DE, USA). cDNA was synthesized using the
MBI Fermentas first strand cDNA synthesis kit. Polymer-
ase chain reaction was performed on Bio-Rad iCycler
(Bio-Rad, Veenendaal, the Netherlands). TaqManW primer
(Roche Molecular Systems, Pleasanton, CA, USA) and
probe sequences for GAPDH (glyceraldehyde-3-phosphate
dehydrogenase) was obtained from Sigma-Aldrich (Haver-




the other genes, we ordered TaqMangene expression as-
says from Applied Biosystems (Nieuwerkerka/dIJssel, the
Netherlands) with the following IDs: LL37; Hs001890
38_m1. TLR3; Hs01551077_m1. Expression changes are
presented as ΔΔct, indicating the difference in threshold
cycle between active sample and negative control, after
correcting for the expression of the housekeeping gene.
Quantitative measurement of LL37 protein
Cells were lysed in RIPA. The protein concentration was
determined using Protein Assay Solution (Beyotime,
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separated on a SDS-PAGE on a 12% glycine-based gel,
followed by being transferred to a polyvinylidene difluoride
membrane (Millipore, USA), and nonspecific binding sites
were blocked. The membrane was incubated with mouse
anti-human LL37 antibody (1:1000 dilution, abcam
ab87701). The membrane was then incubated with the cor-
responding horseradish peroxidase labeled secondary goat
anti-mouse IgG antibody (1:2500). Immunoreactive pro-
teins were detected with the enhanced chemiluminescence
(ECL) western blot detection system (Beyotime, China).
b-actin protein was added as the endogenous reference.
Statistical analysis
Each set of results shown is representative of at least three
separate experiments. Experiments were performed in trip-
licate and values are shown as the mean ± SD. Statistical
significance was determined using the non-parametric
Kruskal–Wallis test for variance. When the result was sig-
nificant, the Mann–Whitney U test was performed for
comparisons between groups (SPSS software). All reported
P values are 2-sided, and values less than 0.05 were consid-
ered to indicate statistical significance.
Results
HDAC inhibitors directly induce LL-37 gene expression in
NCI-H292 human airway epithelial cells
Antibacterial peptides are an integral part of the epithelial
defence barrier that provides immediate protection against
infection. To characterize the role of epigenetics in the ex-
pression of human cathelicidin, we assessed LL-37 expres-
sion with or without of HDAC inhibitors. Compared to
the control group, poly(I:C) by itself slightly increased LL-
37 expression. Importantly, expression of LL-37 in the
presence of poly(I:C) is further increased to 19-fold (p <
0.01) at increasing concentrations of TSA (Figure 1A).
This increase expression induced by TSA seems a direct
effect of TSA as it is also observed in the absence of poly
(I:C) as seen in Figure 1B.
To confirm the findings obtained with TSA, we tested
the effect of other HDAC inhibitor, SB. Like TSA, SB
used at concentrations (1 mM, 2 mM, 4 mM and 8 mM)
dose dependently increased LL37 expression in the NCI-
H292 cell (Figure 1C).
Our results indicate that TSA(200 nM) or SB(4 mM)
stimulation for 24 h could effectively up-regulate LL37
gene expression, so, we use TSA(200 nM) or SB(4 mM)
through our following experiment.
HDAC inhibitors induce cathelicidin LL-37 gene
expression in human primary nasal epithelial cell
The sinonasal tract lined by respiratory epithelium plays
an important role in airway immunity. The only human
cathelicidin LL37 first identified in neutrophils wasshown to be expressed in surface epithelial cells of the
conducting airways [9]. To verify whether HDAC inhibi-
tors induce LL37 gene expression in upper airway epi-
thelial cells, we cultured the human nasal epithelial cells
and performed the stimulation experiments in the pri-
mary cells. Our results demonstrated that the HDAC in-
hibitors had a similar effect on the LL37 mRNA
expression as they did in H292 cells (Figure 2).
HDAC inhibitors up-regulate LL37 protein expression in
NCI-H292 human airway epithelial cells but not in
primary nasal epithelial cells
To analyse the effect of HDAC inhibitors on the LL37
protein expression in the epithelial cells, we treated the
NCI-H292 cells and human primary nasal epithelial cells
with HDAC inhibitors for 24 hours, followed by the
extract of cell total protein and western blot analysis.
Our results indicated that the two HDAC inhibitors in-
duced LL37 protein expression in the NCI-H292 cells.
However, no significant difference of LL37 protein
expression was found in the primary cells (Figure 3).
HDAC inhibitors suppress IL-6 production after poly(I:C)
stimulation
TSA was recently reported to inhibit IL-6 production from
monocytes and macrophages [10]. To determine if HDAC
inhibitors could also suppress IL-6 production in the air-
way epithelium, we treated the H292 cells and primary
nasal epithelial cells with HDAC inhibitors for 2 h prior to
poly(I:C) stimulation. In our experiment, poly(I:C) stimula-
tion for 24 h significantly increased IL-6 protein expression
level in both of the airway epithelial cells. Interestingly, we
found that pre-incubation with HDAC inhibitors inhibited
the IL-6 protein expression in H292 cells (Figure 4A). In
the primary nasal epithelial cells, only SB significantly in-
duced IL-6 expression (Figure 4B).
The effect of HDAC inhibitors on TLR3 expression in
airway epithelial cells
The inhibition of HDAC inhibitors on poly(I:C) induced
expression of IL-6 we observed in the previous experi-
ment could be mediated at many different levels. To ex-
plore whether some of the inhibitory effect could be
upstream of the IL-6 genes we determined TLR3 expres-
sion levels as a measure of different HDAC inhibitors
concentrations. Our results showed that poly(I:C) stimu-
lation without TSA or SB increased the TLR3 expression
by more than one and a half times, and in the presence
of different concentrations of HDAC inhibitors, the in-
duced expression of TLR3 gene expression was not seen
significantly alternative expression(data not shown),
indicating that the inhibition of HDAC inhibitors on
poly(I:C) induced expression of IL-6 was not due to
TLR3 expression levels.
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assessed by the Cell Counting Kit 8. Our data showed that
the stimulation with various concentration of poly(I:C),
TSA or SB had a minimal effect on cell viability.
Discussion
In the present study, we have shown a complex interplay
between epigenetics and aspects of the innate immune re-
action in airway epithelial cells. HDAC inhibitors on one
hand inhibit poly(I:C)-induced expression of IL-6, while
on the other hand they directly induces LL-37 expressionFigure 1 Real-time polymerase chain reaction analysis of
expression of LL-37 in H292 cells in response to poly(I:C) with
or without TSA. (A): The mRNA expression of LL-37 at different
concentration of TSA in response to the poly(I:C). (B): Cells were
stimulated with different concentration of poly(I:C) for 24 h in the
presence or absence of TSA(200 nM). (C): The effect of SB on the
LL37 gene expression. *p<0.05 vs control. Values represent the mean
±SD of three independent experiments.in NCI-H292 human airway epithelial cells. In the primary
nasal epithelial cells, we found that only SB inhibited poly
(I:C)-induced expression of IL-6 and that both TSA and
SB could induce LL37 gene, not protein, expression. Our
results indicate that epigenetic regulation plays an import-
ant, yet complicated, role in the regulation of innate
immunity in airway epithelial cells.
All these observations of inhibition under unstimulated
or stimulated conditions seem contrary to what one would
expect for the action of an inhibitor of deacetylases. As
this inhibition would lead to higher levels of (local) histone
acetylation one might expect increased levels of gene ac-
tivity. In our experiments only the expression of LL-37
seems to follow the expected paradigm. However, TSA
and SB might act indirectly on a target gene by affecting
the expression of some negative regulator only, or in com-
bination with a positive effect on either the target gene it-
self or some positive regulator.
Epithelium derived antimicrobial peptide LL-37 is an
important component of host defense at mucosal sur-
faces and exposure to TLR3 agonist is indeed able to
up-regulate the expression of LL-37 in primary human
corneal epithelial cells [11], just like it was in the airway
epithelial cells. However, the positive effects of TSA and
SB were much stronger than that of the TLR3 activator
and, moreover, this activation does not require the pres-
ence of the TLR3 agonist. The positive effect of TSA
and SB on the gene expression of LL-37 in airway epi-
thelium is consistent with previous study reported
by Schauber et al. that histone-deacetylase inhibitors
(butyrate) induce the cathelicidin LL-37 in gastrointes-
tinal cells. And they further demonstrated that butyrate
induced expression of LL-37 was mediated by MEK-
ERK signalling pathway [12]. The different expression
of LL37 protein in primary nasal epithelial cells and
NCI-H292 cells needs further research.Figure 2 The effect of HDAC inhibitors ( TSA,200 nM; SB,4 Mm)
on the LL37 gene expression in the primary nasal epithelial
cell. *p<0.05 vs control. Values represent the mean±SD of three
independent experiments.
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duced LL37 expression? Emerging evidence indicates that
HDAC inhibitors play an important role in the modulation
of core histone (H3 and H4) and non-histone proteins.
Butyrate and TSA were reported to induce LL37 expression
via acetylation of the non-histone protein HMG-N2
and the histone protein H4 in HT-29 colon, 23132/87 gas-
tric and HepG2 hepatoma cells [12]. LL-37 gene had
potential binding sites for several transcription factors, in-
cluding NF-kB and activator protein-1 [13]. Kuwano et al
[14] reported sodium butyrate induced histone acetylation
of the cathelicidin promoter using the chromatin immuno-
precipitation (ChIP) in the human lung epithelial cell line.
They also indicated that activator protein-1 plays an im-
portant role in the regulation of sodium butyrate-induced
transactivation of cathelicidin promoter. In the present
study, our results revealed that TSA and SB induced LL37
expression both in gene and protein levels in NCI-H292
cells, which is consistent with the previous reports. Unlike
the previously reported effect of HDAC inhibitors on the
LL37 expression, Schauber et al. indicated that HDAC in-
hibitors(TSA and butyrate) alone did not change
cathelicidin transcript abundance in keratinocytes. They
demonstrated that HDAC inhibition significantly amplify
cathelicidin expression in keratinocytes in the presence of
1,25-Dihydroxyvitamin D3 [15]. So, we speculate that
acetylation of cathelicidin promoter play an important role
in LL37 expression. Our results in the nasal epithelial cells
indicated that HDAC inhibitors could induce LL37 gene
expression, but not the LL37 protein. These observations
show that the nature of a response to histone acetylation
will be cell-type and gene-specific.
The airway epithelium itself is responsible for the syn-
thesis and release of cytokines that cause the selective
recruitment, retention, and accumulation of variousFigure 3 The LL37 protein expression induced by HDAC
inhibitors in the NCI-H292 cells and the primary nasal epithelial
cells. Whole cell lysates prepared from the NCI-H292 cells and PNEC
24 h after treatment with TSA(200 nM) and SB(4 mM). Data shown
are from a single representative experiment. These experiments
were repeated at least twice to confirm reproducibility.inflammatory cells [16,17]. Target cells of the epithelium
can respond to a variety of inflammatory mediators and
cytokines. IL-6 is a multifunctional cytokine that regu-
lates the immune response, the acute phase response
and inflammation. IL-6 is involved in the pathogenesis
of lung diseases such as asthma and chronic obstructive
pulmonary disease [18]. Our results demonstrated a sup-
pressive effect on IL-6 expression in TSA-exposed air-
way epithelial cells. These observation are in line with
those of Grabiecet al [15] that also reported that TSA
significantly reduced the production of IL-6 after expos-
ure to multiple stimuli, including poly(I:C), in fibroblast-
like synoviocyte and macrophages. Although this groupFigure 4 ELISA analysis of IL-6 expression in the airway
epithelial cells. The effect of HDAC inhibitors on IL-6 production in
the NCI-H292 cells (A) and the primary nasal epithelial cells (B) in
response to poly(I:C) stimulation. Cells were pretreated respectively
with TSA (200 nM) or SB(4 mM) for 2 h prior to the poly(I:C) (20 ug/
ml) stimulation for 24 h. IL-6 production in cell supernatant was
analyzed using ELISA. *p<0.05 vs control. Values represent the mean
±SD of three independent experiments.
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the inhibitory effect of TSA was a consequence of accel-
erated mRNA decay. Our observation of a direct effect
of TSA on TLR3 is supported by similar observations in
human microglia and astrocytes in their response to
poly(I:C) [19].
In addition to the expression of individual genes, the
global character of the action of TSA is probably also
the reason for its ability to suppress cell growth by indu-
cing cell cycle arrest and to promote differentiation of
normal and transformed cells [20]. Increasing evidence
suggests that HDAC inhibitors are indeed potent anti-
inflammatory and immunomodulatory agents [21,22].
In summary, our results indicate that regulation of his-
tone acetylation and chromatin remodelling plays a com-
plex role in innate immune responses in airway epithelium.
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